CVS Caremark’s David Denton joins Coach board of directors
NEW YORK — Luxury accessories design house Coach has announced the appointment of David Denton, EVP and CFO of CVS Caremark, to is board.
The company also appointed William Nuti, who was named chairman, CEO and president of NCR Corp., to the board. The appointments of Nuti and Denton brings to 11 the number of board members.
“We are extremely pleased that Bill Nuti and Dave Denton have agreed to join our board. As Coach continues to transform into a global modern luxury lifestyle brand, we are confident that their respective business experience, strategic insight and leadership skills will prove particularly valuable to us,” stated Victor Luis, CEO of Coach.
Denton joined CVS Caremark in 1999 and has held various managerial roles throughout the company. Previously, Denton was SVP and controller/chief accounting officer of CVS Caremark and served as CFO and controller for PharmaCare, CVS’ legacy PBM subsidiary. In addition, while at CVS Caremark, he has held positions in corporate treasury, financial planning and analysis and corporate finance.
Navarro Discount Pharmacy launches mobile health station
MIAMI — Navarro Discount Pharmacy has launched a new Mobile Health Station, aimed at improving the community’s health across South Florida by offering free health screenings and the opportunity to get various immunizations — such as the flu, shingles and pneumonia vaccines — at discounted rates.
“As a community based pharmacy, we want to take action to improve the health of all people in Miami-Dade and Broward counties,” stated Albert Garcia, Navarro’s EVP of pharmacy and president of Navarro Health Services. “By branching out into the community, the Mobile Health Station provides people an easy way to connect with physicians, Navarro pharmacists and other health providers to address their health concerns and learn how to take better care of themselves.”
Throughout the year, the Mobile Health Station will travel to different neighborhoods and participate in events throughout South Florida. People will be able to receive a variety of health services, such as free health screenings that include tests for glucose, total cholesterol, body mass index and bone density and immunizations for the flu and shingles. Doctors, nurses, nurse practitioners, pharmacists and health care providers will staff Navarro’s Mobile Health Station.
Valeant Pharmaceuticals licenses Tiazac XC to Actavis
LAVAL, Quebec — Valeant Pharmaceuticals on Monday announced that certain of its subsidiaries have entered into settlement agreements with Actavis related to Actavis’ generic versions of Tiazac XC.
Valeant’s subsidiaries, Valeant Canada and Valeant International Bermuda, and Actavis Pharma Company have entered into an agreement to settle outstanding patent litigation related to Actavis’ generic version of Tiazac XC (diltiazem hydrochloride) 180 mg, 240 mg, 300 mg and 360 mg capsules. Tiazac XC is a calcium cellular influx inhibitor (slow channel blocker) indicated for treatment of hypertension. It is marketed in Canada by Valeant Canada.
Under the terms of the agreement, which is pending approval from the Federal Court of Canada, it will result in a stay of this application until certain events occur and a dismissal of all remaining proceedings and appeals.
Separately, Valeant also granted Actavis license to market generic Acanya gel beginning July 1, 2018.